Cell Therapeutics, Inc. Hires Former BIO VP of Communications
Tuesday February 28, 7:00 am ET
Dan Eramian to Join CTI as EVP of Corporate Communications
[Just what they needed? I am surprised that the guy said yes to the proposal. They must have paid him a nice sum to convince him to take on his new mission. Restoring confidence and morale in CTIC should not be the easiest of tasks. Maybe he is looking forward to the challenge. The best way to restore confidence in the company would otherwise have been to follow the advice of the four now departed board members. But I don't think Eramian is going to suggest that].
SEATTLE, Feb. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC - News) today announced that Dan Eramian, former Vice President of Communications at Biotechnology Industry Organization (BIO), will join the Company in early March as Executive Vice President of Corporate Communications. Eramian will serve as a member of the Company's senior management team and will be responsible for developing and implementing the internal and external communications strategy. Eramian brings nearly 13 years of experience in the biotechnology industry to the position.
ADVERTISEMENT
"We are very pleased to have Dan join the senior management team. His wealth of industry knowledge and experience has earned him the trust and respect of his colleagues," said James A. Bianco, M.D., President and CEO of CTI. "We are confident that his experience and leadership will be an asset to CTI."
Most recently Eramian was Vice President of Communications at BIO, a Washington, DC-based industry organization representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations. Prior to BIO, Eramian was Assistant Administrator of Communications at the Small Business Administration and Director of Public Affairs at the Department of Justice and Chief Spokesman for the Attorney General.
"In my 13 years at BIO, I have worked with scores of fine CEOs and member companies," stated Eramian. "I am especially excited about joining the CTI team and contributing to their bright future."
"CTI has landed a significant asset. Dan Eramian is a highly experienced professional and has performed exceptionally well at the international, national, and local levels without ever losing his rare common touch," noted Carl B. Feldbaum, president emeritus and former president of BIO. |
